Screening mutations in drug-resistant Mycobacterium tuberculosis strains in Yunnan, China
Screening mutations in drug-resistant Mycobacterium tuberculosis strains in Yunnan, China
复制标题
中国云南省结核分枝杆菌耐药菌株突变筛选
DOI:
10.1016/j.jiph.2017.04.008
复制
发表时间:
2017-09-01
影响因子:
6.7
通讯作者:
Zhang, A-Mei
中科院分区:
文献类型:
--
作者:
Li, Daoqun;Song, Yuzhu;Zhang, A-Mei
Drug-resistant tuberculosis (DR-TB), especially multidrug-resistant tuberculosis (MDR-TB), is a seriousmedical and societal problem in China. The purpose of this study was to evaluate the mutation characteristics of drug-resistant Mycobacterium tuberculosis (M. tuberculosis) isolates in Yunnan, China. Drug susceptibility testing (DST) was performed in 523 clinical M. tuberculosis isolates. Six drug resistancegenes (katG, inhA, rpoB, rpsL, embB, and pncA) were selected to screen for mutations. In total, 54 clinical M. tuberculosis strains were identified as drug-resistant by DST, including 18 single drug-resistant( SDR) strains and 36 multidrug-resistant (MDR) strains. Twenty-four types of mutations in five genes( excluding the inhA gene) were screened in forty-one strains. Six novel mutations were identified in thisstudy, including three missense mutations (p. S302R in katG, p. D78G in embB, and p. M1I in pncA), twoframeshift mutations (408 ins A and 538-580 del in pncA), and one mutation in a control region (-6 C>T located upstream of rpsL). The mutation frequencies in the hotspot mutation regions in the katG, rpoB, rpsL, embB, and pncA genes were 92.5%, 44.4%, 54.2%, 52.6%, and 37.5%, respectively. The mutation spectraand frequencies seemed some what unique in the Yunnan DR-TB strains. (C) 2017 The Authors. Published by Elsevier Limited on behalf of King Saud Bin Abdulaziz University for Health Sciences.